Interview with the Innovators

Occurrence of TRK Fusion–Positive Tumors in Different Cancer Types

Ezra Cohen, MD, FRCPSC, FASCO
Professor of Medicine
Chief
Division of Hematology/Oncology
UC San Diego
La Jolla, CA
Mary Jo Fidler, MD
Associate Professor and Section Chief
Medical Oncology
Rush University Medical Center
Chicago, IL
Arturo Loaiza-Bonilla, MD, MSEd, FACP
Enterprise Medical Director of Research
Comprehensive Care and Research Center
Philadelphia, PA
Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, confer on the categorization of various cancer types in which NTRK gene fusions may be detected.

Related Articles

Subscribe to
Oncology Practice Management

Stay up to date with oncology news & updates by subscribing to receive the free OPM print publications or weekly e‑Newsletter.

I'd like to receive: